Immediate Impact

4 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Conquering the Hypoxia Limitation for Photodynamic Therapy
2021 Standout
NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation
2021 Standout
2 intermediate papers

Works of W D Figg being referenced

A randomized phase II trial of thalidomide, an angiogenesis inhibitor, in patients with androgen-independent prostate cancer.
2001
A Phase II study of high-dose tamoxifen in patients with hormone-refractory prostate cancer.
1999

Author Peers

Author Last Decade Papers Cites
W D Figg 219 145 97 6 353
Albaha Barqawi 185 104 162 10 343
Susan D’Aloisio 127 258 139 7 402
Andrei Y. Volgin 141 162 121 7 351
C. S. Killian 237 114 97 11 409
Farhat Ghaznawi 230 162 211 10 405
Heléne Gustavsson 222 216 131 10 389
Susan K. Roethke 227 117 124 6 329
Su-Ing Hii 176 203 70 6 362
M. Toi 55 126 108 7 338
R. C. Horns 57 157 172 10 404

All Works

Loading papers...

Rankless by CCL
2026